AstraZeneca PLC (AZN) vs Johnson & Johnson (JNJ)
AZN leads on 11 of 16 compared metrics.
A side-by-side comparison of AstraZeneca PLC and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs JNJ
growth of $100 · last 30yAZN +723.4%JNJ +885.6%JNJ compounded faster
AZN JNJ
AZN vs JNJ: by the numbers
- •JNJ is the larger company ($579.83B vs $277.22B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 27.85 P/E).
- •JNJ converts more revenue to profit (21.83% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 2.99% CAGR).
- •JNJ pays the higher dividend yield (2.18% vs 1.79%).
Which is better, AZN or JNJ?
Metric tally: AZN 11 · JNJ 5It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeJNJ(higher dividend yield)
QualityJNJ(higher ROIC)
Valuation
| Metric | AZN | JNJ |
|---|---|---|
| P/E ratio | 26.92● | 27.85 |
| Forward P/E | 15.33● | 18.87 |
| P/S ratio | 4.62● | 6.11 |
| P/B ratio | 5.90● | 7.25 |
| PEG ratio | 0.14● | 0.21 |
| EV / EBITDA | 14.92● | 18.71 |
| FCF yield | 3.26%● | 3.02% |
Profitability
| Metric | AZN | JNJ |
|---|---|---|
| Gross margin | 81.68%● | 69.12% |
| Operating margin | 23.69% | 26.87%● |
| Net margin | 17.19% | 21.83%● |
| ROE | 21.95% | 25.92%● |
| ROIC | 13.03% | 13.71%● |
Dividends
| Metric | AZN | JNJ |
|---|---|---|
| Dividend yield | 1.79% | 2.18%● |
| Payout ratio | 48.48% | 47.51% |
Growth (annualized)
| Metric | AZN | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 2.99% |
| EPS CAGR (5Y) | 22.02%● | 11.51% |
| FCF CAGR (5Y) | 18.52%● | -2.38% |
| Total return CAGR (5Y) | 11.03% | 10.93% |
Frequently asked
- Which is better, AZN or JNJ?
- It depends on your goal. value: AZN (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: JNJ (higher dividend yield); quality: JNJ (higher ROIC). Across all compared metrics, AZN leads 11 to 5.
- Is AZN or JNJ cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and JNJ at 27.85.
- Which has grown faster, AZN or JNJ?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus JNJ at 2.99%.
- Does AZN or JNJ pay a bigger dividend?
- AZN yields 1.79% and JNJ yields 2.18% based on trailing dividends and the latest price.
- Is AZN or JNJ more profitable?
- JNJ runs the higher net margin — AZN at 17.19% versus JNJ at 21.83%.
- Which has been the better investment, AZN or JNJ?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus JNJ at 10.46%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioJohnson & Johnson P/E ratioAstraZeneca dividend yieldJohnson & Johnson dividend yieldAstraZeneca ROEJohnson & Johnson ROEAstraZeneca operating marginJohnson & Johnson operating marginAstraZeneca revenue growthJohnson & Johnson revenue growthAstraZeneca free cash flowJohnson & Johnson free cash flow
AstraZeneca & Johnson & Johnson appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.